Modeling Disease In Vivo With CRISPR/Cas9

Area of Science:

• Genetics and Genomics
• Molecular Biology
• Biotechnology

Background:

• CRISPR/Cas9 genome editing technology has emerged as a revolutionary tool in biological research.
• Its simplicity and effectiveness enable precise genomic manipulation across diverse cell types.
• The technology is derived from an adaptive bacterial immune system.

Purpose of the Study:

• To discuss the current applications of CRISPR technology.
• To highlight the development of novel in vivo disease models using CRISPR.
• To emphasize the utility of CRISPR in modeling human cancer complexity.

Main Methods:

• CRISPR/Cas9-mediated genome editing.
• Development of in vivo models.
• Application in cancer research.

Main Results:

• CRISPR/Cas9 has become a preferred tool for genetic manipulation.
• The technology facilitates the creation of new in vivo disease models.
• CRISPR-derived tools enhance the modeling of human cancer.

Conclusions:

• CRISPR/Cas9 technology provides a promising platform for studying gene function in vivo.
• Its application in creating disease models, especially for cancer, is rapidly advancing.
• This technology holds significant potential for future biomedical research and therapeutic development.